Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

60 Degrees Pharmaceuticals (SXTP) Tax Provisions (2022 - 2025)

60 Degrees Pharmaceuticals (SXTP) has disclosed Tax Provisions for 4 consecutive years, with $63.0 as the latest value for Q1 2025.

  • On a quarterly basis, Tax Provisions changed 0.0% to $63.0 in Q1 2025 year-over-year; TTM through Mar 2025 was $250.0, a 0.0% change, with the full-year FY2024 number at $250.0, changed 0.0% from a year prior.
  • Tax Provisions was $63.0 for Q1 2025 at 60 Degrees Pharmaceuticals, up from -$501.0 in the prior quarter.
  • In the past five years, Tax Provisions ranged from a high of $438.0 in Q2 2024 to a low of -$501.0 in Q4 2024.
  • A 4-year average of $51.18 and a median of $63.0 in 2023 define the central range for Tax Provisions.
  • Biggest YoY gain for Tax Provisions was 595.24% in 2024; the steepest drop was 921.31% in 2024.
  • 60 Degrees Pharmaceuticals' Tax Provisions stood at -$250.0 in 2022, then surged by 124.4% to $61.0 in 2023, then plummeted by 921.31% to -$501.0 in 2024, then soared by 112.57% to $63.0 in 2025.
  • Per Business Quant, the three most recent readings for SXTP's Tax Provisions are $63.0 (Q1 2025), -$501.0 (Q4 2024), and $250.0 (Q3 2024).